Yoshiyama Annie
- SEC CIK
- 0001835208
In the past year, 2 open-market sale filings worth $29.3K and no purchases.
Current role at each company
- ALLO Allogene Therapeutics, Inc.SVP, Financeas of Apr 23, 2026
- TCDA Tricida, Inc.Senior VP, Finance and CAOas of Aug 9, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $29.3K
- 2 filings
- Net
- −$29.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Yoshiyama Annie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALLO Allogene Therapeutics, Inc.
SVP, Finance3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 (view filing) | Apr 21 | 2 days | Yoshiyama AnnieSVP, Finance | SSale | −9.59K | $2.31 | −$22.1K | −7.1%124.5K after | |
| Feb 4, 2026 (view filing) | Feb 2 | 2 days | Yoshiyama AnnieSVP, Finance | SSale | −4.17K | $1.72 | −$7.17K | −3.1%130.3K after | |
| Apr 23, 2025 (view filing) | Apr 21 | 2 days | Yoshiyama AnnieSVP, Finance | SSale | −9.60K | $1.41 | −$13.5K | −6.8%130.7K after |